Christie + Co
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Interserve-led consortium left as final bidder for cancer contract

A consortium led by Interserve Investments is the only remaining bidder for the £687 million contract to provide cancer services in Staffordshire.

Interserve Investments’ consortium also includes The Royal Wolverhampton Hospitals NHS Trust and the University Hospitals of North Midlands NHS Trust.

The two trusts were originally each separate bidders and among the five parties who made it through the pre-qualification stage for the contract before teaming up with Interserve Investments.

CSC Computer Sciences and United Health UK were the other two organisations to pre-qualify. Both, however, pulled out of the process.

In a statement to HSJ, the clinical commissioning groups tendering the contract said: "During the competitive dialogue with bidders on the programme, a number of individual organisations and providers came together and formed a bidding consortium.

"This brings together the public and private sector, including two local NHS trusts.

"It will bring together a wide range of skills and expertise to implement this innovative approach to the commissioning of cancer care.

"The consortium is the last remaining bidder."

The consortium has to submit a formal proposal over the next few months before the contract is awarded in December.

The cancer services contract is one half of a wider procurement process, worth £1.2 billion in total, being carried out by the four local clinical commissioning groups (CCGs). An end-of-life contract, with a value of £535 million, is also being tendered out.

Cannock Chase CCG, North Staffordshire CCG, Stafford & Surrounds CCG and Stoke-on-Trent CCG are the four CCGs tendering out the two contracts.

NHS Strategic Projects Team is running the process.


Related articles:

Posted on: 04/06/2015

Latest news stories

24/03/2017
Over 70% of healthcare-related properties across England and Wales will see their business rates rise when the rates revaluation comes into effect on 1 April.
23/03/2017
CareTech has successfully raised £39 million before expenses through the placing of 11 million new shares at 355 pence per share.
23/03/2017
Mears group left one fifth of its care contracts in 2016, contributing to a £1.2 million loss for its care business.
22/03/2017
Aim-listed CareTech has announced it will make a placing of 11 million new ordinary shares at 355 pence each in a bid to raise approximately £39 million.
22/03/2017
The Care Quality Commission has warned of problems with the safety of care offered by independent ambulance providers, following inspections.




Interview: Paolo Pieri

After a first decade or so rarely out of the limelight, Circle's next act is all about scale, CEO Paolo Pieri tells Ploy Radford
Read more...



Company profile: IMH Group

IMH CEO Richard Power tells Sarah Williams how the company is taking the strain off the struggling primary care sector
Read more...
HealthInvestor Events

Social care staffing' already under strain, could face further pressure after Brexit. Sarah Williams asks sector leaders about their biggest fears - and what could allay them
Read more...


Christie + Co


Learning disabilities

The CQC has been accused of 'unlawfully' refusing to register LD units with over six beds. Ploy Radford takes a look at the issue which has got the LD sector up in arms
Read more...



HealthInvestor blog
STPs could hinder much-needed private sector partnerships if 'accountable care' is enforced incorrectly, argues NHS Partners CEO David Hare

Click here to view the Editor's blog


Claire Smith is the chief executive of HCA Joint Ventures and an avid dog walker
Dr Michelle Tempest and Dr Niklas Jahn of Candesic diagnose the investment case for the orthopaedic hip and knee joint replacement market
Clare Connell and Henry Hunt of Connell Consulting take a look at how rising fuel costs will affect health and social care
Social care staffing, already under strain, could face further pressure after Brexit. Sarah Williams asks sector leaders about their biggest fears – and what could allay them
IMH CEO Richard Power tells Sarah Williams how the company is taking the strain off the struggling primary care sector

Click here to search all feature articles